Skip to main content
The BMJ logoLink to The BMJ
editorial
. 1994 Nov 19;309(6965):1314–1315. doi: 10.1136/bmj.309.6965.1314

Finding a way through the cost and benefit maze.

A Szczepura
PMCID: PMC2541882  PMID: 7866071

Full text

PDF
1314

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hayward J. Purchasing clinically effective care. BMJ. 1994 Oct 1;309(6958):823–824. doi: 10.1136/bmj.309.6958.823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. McMurray J., Rankin A. Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris. BMJ. 1994 Nov 19;309(6965):1343–1350. doi: 10.1136/bmj.309.6965.1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. McNeil B. J. Use of claims data to monitor patients over time: acute myocardial infarction as a case study. Ann N Y Acad Sci. 1993 Dec 31;703:63–73. doi: 10.1111/j.1749-6632.1993.tb26336.x. [DOI] [PubMed] [Google Scholar]
  4. Simoons M. L., Vos J., Martens L. L. Cost-utility analysis of thrombolytic therapy. Eur Heart J. 1991 Jun;12(6):694–699. doi: 10.1093/eurheartj/12.6.694. [DOI] [PubMed] [Google Scholar]
  5. Vermeer F., Simoons M. L., de Zwaan C., van Es G. A., Verheugt F. W., van der Laarse A., van Hoogenhuyze D. C., Azar A. J., van Dalen F. J., Lubsen J. Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands. Br Heart J. 1988 May;59(5):527–534. doi: 10.1136/hrt.59.5.527. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES